← Leaderboards
Richard T Lee
Harvard University
$35,154,583
Attributed
$35,962,783
Total exposure
29
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,962,783 · 29
By mechanism
R01$31,061,814 · 20
P01$2,522,641 · 3
DP3$1,250,000 · 1
R03$508,238 · 2
R56$346,450 · 1
S10$180,390 · 1
Top collaborators
- Peter C Dedon4 shared
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoCardiac MyocytesPathway InteractionsProteinsCellsMolecularUnited StatesHeartIn VitroSignal TransductionHeart FailureMyocardiumBaseResearch StudyCardiacLeadTissuesLaboratoriesStructureMyocardialInsightGenesAdultMetabolic
Grant awards (106)
Mitochondrial Gene Editing in Human Cardiomyocytes$773,479
R01 · FY2025 · HL · contact PI
Myocardial Physiology of Growth Differentiation Factor Signaling$608,473
R01 · FY2025 · HL · contact PI
Myocardial Physiology of Growth Differentiation Factor Signaling$596,303
R01 · FY2024 · HL · contact PI
Molecular Mechanisms of Arrestin-Domain Containing Proteins in Metabolism$405,600
R01 · FY2024 · DK · contact PI
Myocardial Physiology of Growth Differentiation Factor Signaling$608,473
R01 · FY2023 · HL · contact PI
Molecular Mechanisms of Arrestin-Domain Containing Proteins in Metabolism$422,500
R01 · FY2023 · DK · contact PI
Molecular Quiescence and Cardiomyocyte Maturation$422,500
R01 · FY2023 · HL · contact PI
Molecular Quiescence and Cardiomyocyte Maturation$422,500
R01 · FY2022 · HL · contact PI
Molecular Mechanisms of Arrestin-Domain Containing Proteins in Metabolism$422,500
R01 · FY2022 · DK · contact PI
Novel Age-Dependent DNA Modifications$404,100
R01 · FY2022 · AG · contact PI
Complement Activation and Initiation of Heart Regeneration$422,500
R01 · FY2021 · HL · contact PI
Molecular Mechanisms of Arrestin-Domain Containing Proteins in Metabolism$422,500
R01 · FY2021 · DK · contact PI
Molecular Quiescence and Cardiomyocyte Maturation$422,500
R01 · FY2021 · HL · contact PI
Novel Age-Dependent DNA Modifications$404,100
R01 · FY2021 · AG · contact PI
Complement Activation and Initiation of Heart Regeneration$422,500
R01 · FY2020 · HL · contact PI
Molecular Quiescence and Cardiomyocyte Maturation$422,500
R01 · FY2020 · HL · contact PI
Novel Age-Dependent DNA Modifications$404,100
R01 · FY2020 · AG · contact PI
Regulation of Fructose Transport by Thioredoxin-Interacting Protein$380,250
R01 · FY2020 · DK · contact PI
In vivo Structure-Function relationships of GDF11 and GDF8$346,450
R56 · FY2020 · AG · contact PI
Reprogramming Non-myocytes to Cardiomyocytes in vivo$427,812
R01 · FY2019 · HL · contact PI
Complement Activation and Initiation of Heart Regeneration$422,500
R01 · FY2019 · HL · contact PI
Novel Age-Dependent DNA Modifications$404,100
R01 · FY2019 · AG · contact PI
Regulation of Fructose Transport by Thioredoxin-Interacting Protein$380,250
R01 · FY2019 · DK · contact PI
A New Pathway for Reversing Cardiac Aging$346,450
R01 · FY2019 · AG · contact PI
Myocardial Effects of Caloric Restriction in Primates$84,500
R03 · FY2019 · AG · contact PI
Reprogramming Non-myocytes to Cardiomyocytes in vivo$427,812
R01 · FY2018 · HL · contact PI
Complement Activation and Initiation of Heart Regeneration$422,500
R01 · FY2018 · HL · contact PI
Novel Age-Dependent DNA Modifications$421,350
R01 · FY2018 · AG · contact PI
Regulation of Fructose Transport by Thioredoxin-Interacting Protein$380,250
R01 · FY2018 · DK · contact PI
A New Pathway for Reversing Cardiac Aging$346,450
R01 · FY2018 · AG · contact PI
Myocardial Effects of Caloric Restriction in Primates$84,500
R03 · FY2018 · AG · contact PI
Reprogramming Non-myocytes to Cardiomyocytes in vivo$427,812
R01 · FY2017 · HL · contact PI
Regulation of Fructose Transport by Thioredoxin-Interacting Protein$380,250
R01 · FY2017 · DK · contact PI
A New Pathway for Reversing Cardiac Aging$346,450
R01 · FY2017 · AG · contact PI
Reprogramming Non-myocytes to Cardiomyocytes in vivo$445,062
R01 · FY2016 · HL · contact PI
Regulation of Fructose Transport by Thioredoxin-Interacting Protein$380,250
R01 · FY2016 · DK · contact PI
Biasing Myocardial Neuregulin Signaling with Engineered Ligands$293,346
R01 · FY2016 · HL · contact PI
A New Pathway for Reversing Cardiac Aging$251,908
R01 · FY2016 · AG · contact PI
Circulating FSTL3 and Age-related Cardiac Hypertrophy$139,204
R03 · FY2016 · AG · contact PI
Biasing Myocardial Neuregulin Signaling with Engineered Ligands$126,054
R01 · FY2016 · HL · contact PI
A New Pathway for Reversing Cardiac Aging$92,902
R01 · FY2016 · AG · contact PI
Circulating FSTL3 and Age-related Cardiac Hypertrophy$30,546
R03 · FY2016 · AG · contact PI
Biasing Myocardial Neuregulin Signaling with Engineered Ligands$413,109
R01 · FY2015 · HL · contact PI
Cardiomyocyte Lineage and Turnover by Metabolic Fate-Mapping$369,017
R01 · FY2015 · AG · contact PI
A New Pathway for Reversing Cardiac Aging$344,660
R01 · FY2015 · AG · contact PI
Circulating FSTL3 and Age-related Cardiac Hypertrophy$169,488
R03 · FY2015 · AG · contact PI
Biasing Myocardial Neuregulin Signaling with Engineered Ligands$410,653
R01 · FY2014 · HL · contact PI
THIOREDOXIN-INTERACTING PROTEIN IN ENDOTHELIAL AND ORGANISMAL METABOLISM$402,339
P01 · FY2014 · HL · contact PI
Cardiomyocyte Lineage and Turnover by Metabolic Fate-Mapping$380,430
R01 · FY2014 · AG · contact PI
Engineering a Cell-Based Glucose Monitor$1,250,000
DP3 · FY2013 · DK · contact PI
Diabetic Cardiomyopathy and the Alpha Arrestin Proteins$398,387
R01 · FY2013 · HL · contact PI
Biasing Myocardial Neuregulin Signaling with Engineered Ligands$398,047
R01 · FY2013 · HL · contact PI
THIOREDOXIN-INTERACTING PROTEIN IN ENDOTHELIAL AND ORGANISMAL METABOLISM$390,844
P01 · FY2013 · HL · contact PI
Interleukin-33 and Myocardial Pressure Overload$387,288
R01 · FY2013 · HL · contact PI
Cardiomyocyte Lineage and Turnover by Metabolic Fate-Mapping$359,506
R01 · FY2013 · AG · contact PI
Aging and Myocardial Progenitor Recruitment$303,011
R01 · FY2013 · AG · contact PI
Diabetic Cardiomyopathy and the Alpha Arrestin Proteins$418,473
R01 · FY2012 · HL · contact PI
THIOREDOXIN-INTERACTING PROTEIN IN ENDOTHELIAL AND ORGANISMAL METABOLISM$410,550
P01 · FY2012 · HL · contact PI
Interleukin-33 and Myocardial Pressure Overload$406,816
R01 · FY2012 · HL · contact PI
Cardiomyocyte Lineage and Turnover by Metabolic Fate-Mapping$380,430
R01 · FY2012 · AG · contact PI
Aging and Myocardial Progenitor Recruitment$320,646
R01 · FY2012 · AG · contact PI
Diabetic Cardiomyopathy and the Alpha Arrestin Proteins$422,425
R01 · FY2011 · HL · contact PI
THIOREDOXIN-INTERACTING PROTEIN IN ENDOTHELIAL AND ORGANISMAL METABOLISM$410,550
P01 · FY2011 · HL · contact PI
Interleukin-33 and Myocardial Pressure Overload$410,071
R01 · FY2011 · HL · contact PI
Cardiomyocyte Lineage and Turnover by Metabolic Fate-Mapping$380,265
R01 · FY2011 · AG · contact PI
Aging and Myocardial Progenitor Recruitment$320,646
R01 · FY2011 · AG · contact PI
Aging and Myocardial Progenitor Recruitment$431,605
R01 · FY2010 · AG · contact PI
Diabetic Cardiomyopathy and the Alpha Arrestin Proteins$421,600
R01 · FY2010 · HL · contact PI
THIOREDOXIN-INTERACTING PROTEIN IN ENDOTHELIAL AND ORGANISMAL METABOLISM$409,946
P01 · FY2010 · HL · contact PI
Interleukin-33 and Myocardial Pressure Overload$409,900
R01 · FY2010 · HL · contact PI
Interleukin-33 and Myocardial Pressure Overload$409,558
R01 · FY2009 · HL · contact PI
Aging and Myocardial Progenitor Recruitment$334,284
R01 · FY2009 · AG · contact PI
Aging and Myocardial Progenitor Recruitment$99,906
R01 · FY2009 · AG · contact PI
Aging and Myocardial Progenitor Recruitment$98,946
R01 · FY2009 · AG · contact PI
Endothelial-Cardiomyocyte Interactions and Assembly$507,029
R01 · FY2008 · HL · contact PI
VDUP1/thioredoxin and cardiomyocyte stress$405,417
R01 · FY2008 · HL · contact PI
VDUP1/thioredoxin and cardiomyocyte stress$405,417
R01 · FY2007 · HL · contact PI
Endothelial-Cardiomyocyte Interactions and Assembly$402,029
R01 · FY2007 · HL · contact PI
Endothelial-Cardiomyocyte Interactions and Assembly$105,000
R01 · FY2007 · HL · contact PI
Endothelial-Cardiomyocyte Interactions and Assembly$422,294
R01 · FY2006 · HL · contact PI
VDUP1/thioredoxin and cardiomyocyte stress$417,525
R01 · FY2006 · HL · contact PI
PF # 4: Development of an Injectable, Self-Assembling Tissue Engineering Scaff$25,000
P30 · FY2006 · AR · contact PI
VDUP1/thioredoxin and cardiomyocyte stress$477,795
R01 · FY2005 · HL
Endothelial-Cardiomyocyte Interactions and Assembly$423,807
R01 · FY2005 · HL
Mechanotransduction in Cardiomyocytes$249,206
P01 · FY2005 · HL
Cell Isolation and Cell Culture Laboratory$249,206
P01 · FY2005 · HL
Endothelial-Cardiomyocyte Interactions and Assembly$42,269
R01 · FY2005 · HL
PF # 4: Development of an Injectable, Self-Assembling Tissue Engineering Scaff$25,000
P30 · FY2005 · AR
VDUP1/thioredoxin and cardiomyocyte stress$427,573
R01 · FY2004 · HL
Left Ventricular Remodeling by Matrix Metabolism$400,815
R01 · FY2004 · HL
PF # 4: Development of an Injectable, Self-Assembling Tissue Engineering Scaff$43,250
P30 · FY2004 · AR
VDUP1/thioredoxin and cardiomyocyte stress$35,788
R01 · FY2004 · HL
Left Ventricular Remodeling by Matrix Metabolism$431,747
R01 · FY2003 · HL
Left Ventricular Remodeling by Matrix Metabolism$400,815
R01 · FY2002 · HL
Left Ventricular Remodeling by Matrix Metabolism$30,873
R01 · FY2002 · HL
Mechanotransduction in Cardiomyocytes$0
P01 · FY2002 · HL
Cell Isolation and Cell Culture Laboratory$0
P01 · FY2002 · HL
Left Ventricular Remodeling by Matrix Metabolism$400,815
R01 · FY2001 · HL
MOLECULAR RESPONSE OF HUMAN MACROPHAGES TO DEFORMATION$296,625
R01 · FY2001 · HL
CARDIOMYOCYTE MECHANOTRANSDUCTION AND THE CARDIAC CYCLE$187,977
R01 · FY2001 · HL
SONOS 5500 IMAGING SYSTEM$180,390
S10 · FY2001 · RR
Cell Isolation and Cell Culture Laboratory$0
P01 · FY2001 · HL
Mechanotransduction in Cardiomyocytes$0
P01 · FY2001 · HL
MOLECULAR RESPONSE OF HUMAN MACROPHAGES TO DEFORMATION$296,625
R01 · FY2000 · HL
CARDIOMYOCYTE MECHANOTRANSDUCTION AND THE CARDIAC CYCLE$289,328
R01 · FY2000 · HL
MECHANICS AND VASCULAR REMODELING BY SMOOTH MUSCLE CELLS$113,686
R01 · FY2000 · HL